Q1-rapporten tas godt i mot, aksjen opp nesten 6 %
1 Like
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-ceo-step-down-2025-05-16/
"Novo Nordisk ousts CEO after falling behind in weight loss market"
Så da var Lars Lars Fruergaard Jorgensens åtte år som CEO i NVO over. Selv sier han at han er overrasket, så han blir vel fjerna med eller mot egen vilje.
Camilla Sylvest (head of commercial strategy and corporate affairs) slutta forrige måned uten å oppgi noen grunn.
Something is rotten in the state of Denmark?
“Novo Nordisk Foundation, the non-profit which controls the company through its investment arm, instigated the early exit at a meeting in April, a spokesperson said.”
“Former CEO of Novo Nordisk for 16 years and current chair of the Novo Nordisk Foundation, Lars Rebien Sorensen, will join the board as an observer with immediate effect with the aim of taking a seat at the next annual general meeting, Novo said.”
2 Likes